Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
2010 Standout
Colorectal cancer statistics, 2020
2020 Standout
Colorectal cancer statistics, 2023
2023 Standout
CD40L induces multidrug resistance to apoptosis in breast carcinoma and lymphoma cells through caspase independent and dependent pathways
2006
Cancer treatment and survivorship statistics, 2022
2022 Standout
Cancer statistics, 2019
2019 Standout
Breast cancer statistics, 2019
2019 Standout
Expanding global access to radiotherapy
2015 Standout
Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma
2005
Natural Health Products That Inhibit Angiogenesis: A Potential Source for Investigational New Agents to Treat Cancer—Part 1
2006 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Global Cancer Statistics, 2002
2005 Standout
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL
2004
The Levels of Evidence and Their Role in Evidence-Based Medicine
2011 Standout
Ongoing Care of Patients After Primary Treatment for Their Cancer
2003
Is there a role for post-operative adjuvant radiation in breast cancer? Beautiful hypothesis versus ugly facts: 1987 Gilbert H. Fletcher lecture
1988
Local Surgical, Ablative, and Radiation Treatment of Metastases
2009
Angiogenesis: an organizing principle for drug discovery?
2007 Standout
Ethnic variations in diagnosis, treatment, socioeconomic status, and survival in a large population‐based cohort of elderly patients with non‐Hodgkin lymphoma
2008
TFOS DEWS II pathophysiology report
2017 Standout
Tolerance of Radiotherapy Combined with Adjuvant Chemotherapy in Breast Cancer
1987
Primary Thyroid Lymphoma: A Clinical Review
2013
Non-Hodgkin's Lymphomas
2002
Targeting multidrug resistance in cancer
2006 Standout
Radioimmunotherapy of non-Hodgkin’s lymphoma: a critical appraisal
2005
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Orbital lymphoma: radiotherapy outcome and complications
2001
Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP
2007
Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin’s disease and non-Hodgkin’s lymphoma
2002
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Failure to Adhere to Protocol Specified Radiation Therapy Guidelines Was Associated With Decreased Survival in RTOG 9704—A Phase III Trial of Adjuvant Chemotherapy and Chemoradiotherapy for Patients With Resected Adenocarcinoma of the Pancreas
2011
Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy
1997 Standout
Primary brain tumours in adults
2012 Standout
Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable
2019 Standout
Pharmacokinetic and Pharmacodynamic Implications of P‐glycoprotein Modulation
2001
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
Modes of resistance to anti-angiogenic therapy
2008 Standout
Diffuse large B-cell lymphoma
2013
Breast Lymphoma Associated With Breast Implants: Two Case-reports and a Review of the Literature
2002
Development of Multidrug-Resistance Convertors: Sense or Nonsense?
2000
Single-Agent Pixantrone as a Bridge to Autologous Stem Cell Transplantation in a Patient with Refractory Diffuse Large B-Cell Lymphoma
2017 Standout
Riding the Crest of the Teachable Moment: Promoting Long-Term Health After the Diagnosis of Cancer
2005 Standout
Antiangiogenic therapy for cancer: current and emerging concepts.
2005
State-of-the-Art Therapeutics: Diffuse Large B-Cell Lymphoma
2005
Molecular Properties That Influence the Oral Bioavailability of Drug Candidates
2002 Standout
Breast Cancer Statistics, 2022
2022 Standout
Revised Response Criteria for Malignant Lymphoma
2007 Standout
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Importance of Radiotherapy in the Outcome of Patients With Primary CNS Lymphoma: An Analysis of the CHOD/BVAM Regimen Followed by Two Different Radiotherapy Treatments
2002
Clinical implications of antiangiogenic therapies.
2005
Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma.
2002
Colorectal cancer statistics, 2017
2017 Standout
Spermidine in health and disease
2018 StandoutScience
Treatment Selection and Survival Outcomes in Early-Stage Diffuse Large B-Cell Lymphoma: Do We Still Need Consolidative Radiotherapy?
2015
Cancer treatment and survivorship statistics, 2016
2016 Standout
Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity
2014
Clinical Efficacy, Tolerability, and Safety of SAM486A, a Novel Polyamine Biosynthesis Inhibitor, in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma
2004
Diffuse large cell lymphoma
2011
Cancer treatment and survivorship statistics, 2019
2019 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Guidelines for the management of thyroid cancer
2014 Standout
Phase II Multicenter Study of Brief Single-Agent Methotrexate Followed by Irradiation in Primary CNS Lymphoma
2000
Quinine as a multidrug resistance inhibitor: a phase 3 multicentric randomized study in adult de novo acute myelogenous leukemia
2003
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of Ellen Chase being referenced
A phase I/II trial of paclitaxel for non-Hodgkinʼs lymphoma followed by paclitaxel plus quinine in drug-resistant disease
1998
Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's Lymphoma
1998
The phenomenon of multidrug resistance in non-Hodgkin’s lymphoma
1997
Adjuvant Treatment of Node-Positive Breast Cancer with Adriamycin-Cyclophosphamide with or Without Radiation Therapy: Interim Results of an Ongoing Clinical Trial
1982